HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Distinct structural TCR repertoires in naturally occurring versus vaccine-induced CD8+ T-cell responses to the tumor-specific antigen NY-ESO-1.

Abstract
Spontaneous immune responses to the cancer testis antigen NY-ESO-1 are frequently found in cancer patients bearing antigen-expressing tumors. In HLA-A2-expressing patients, naturally elicited NY-ESO-1-specific, tumor-reactive cytotoxic T lymphocytes (CTLs) are mostly directed against an immunodominant epitope corresponding to peptide NY-ESO-1 157-165. NY-ESO-1-specific CTLs can also be induced by synthetic peptide vaccines, but they are heterogeneous in terms of functional avidity and tumor reactivity. The authors investigated the structural bases of this phenomenon by analyzing the TCR features of natural and vaccine-induced NY-ESO-1-specific CTLs. The results indicate that CTLs from the two groups exhibit highly structurally conserved but distinct TCR features, suggesting that the synthetic peptides used for vaccination may fail to faithfully mimic the naturally processed antigen. Together, the results of this study underline the strength of TCR molecular monitoring and will be instrumental for the development and monitoring of vaccines aimed at eliciting CTLs with high tumor reactivity.
AuthorsFrédérique-Anne Le Gal, Maha Ayyoub, Valérie Dutoit, Valérie Widmer, Elke Jäger, Jean-Charles Cerottini, Pierre-Yves Dietrich, Danila Valmori
JournalJournal of immunotherapy (Hagerstown, Md. : 1997) (J Immunother) 2005 May-Jun Vol. 28 Issue 3 Pg. 252-7 ISSN: 1524-9557 [Print] United States
PMID15838382 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Neoplasm
  • Cancer Vaccines
  • Neoplasm Proteins
  • Peptide Fragments
  • Receptors, Antigen, T-Cell
  • Vaccines, Subunit
  • peptide NY-ESO-1 157-165
Topics
  • Amino Acid Sequence
  • Antigens, Neoplasm (immunology)
  • Cancer Vaccines (immunology)
  • Humans
  • Molecular Sequence Data
  • Neoplasm Proteins (immunology)
  • Peptide Fragments (immunology)
  • Receptors, Antigen, T-Cell (chemistry)
  • T-Lymphocytes, Cytotoxic (immunology)
  • Vaccines, Subunit (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: